| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790002 | Urologic Oncology: Seminars and Original Investigations | 2018 | 9 Pages |
Abstract
Overall, men with PCa were more likely to die from non-PCa related outcomes. Nevertheless, the analyses showed a high proportion of PCSM among men on ADT, older men and men with a high-risk tumor. However, further research is needed to understand comprehensively the benefits of the respective treatments.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Katarina L. M.Sc., Giulia M.Sc., Dimitri M.D., Mieke Ph.D., Sabine Ph.D.,